Navigation Links
Delcath Expands Board of Directors With Appointment of Gabriel Leung
Date:3/31/2011

–looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to the acceptability of the Phase III clinical trial data by the FDA, re-submission and acceptance of the Company's NDA by the FDA, approval of the Company's NDA for the treatment of metastatic melanoma to the liver, adoption, use and resulting sales in the United States, acceptance of the Company's CE Mark Technical File by its Notified Body, receipt of CE Mark approval, adoption, use and resulting sales in the EU, if any, our ability to successfully commercialize the chemosaturation system and the potential of the chemosaturation system as a treatment for patients with terminal metastatic disease in the liver, approval of the current or future chemosaturation system for other indications, actions by the FDA or other regulatory agencies, our ability to successfully enter into distribution and strategic partnership agreements in foreign markets and the corresponding revenue associated with such foreign markets, and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward–looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward–looking statements to reflect events or circumstances after the date they are made.Investor Contact:

Media Contact:Gregory Gin/Doug Sherk

Janine McCargoEVC Group

EVC Group646-455-4801/415-896-6818

646-528-4034
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath to Present at Upcoming Investor Conferences
2. Delcath Systems Receives Refusal to File Letter From FDA
3. Delcath Achieves ISO 13485 Certification
4. Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System
5. Delcath Systems Announces Third Quarter Progress Report Conference Call
6. Delcath Strengthens Research and Development Team with Key Appointments
7. Delcath Signs Agreement With Synerx and Mylans Bioniche Teoranta for Melphalan Supply
8. Delcath to Present at the William Blair Emerging Growth Stock Conference
9. Delcath to Present at the JMP Securities Healthcare Conference
10. Delcath Systems Announces Completion of Common Stock Offering
11. Delcath to Present at the 30th Annual Canaccord Global Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. ... a U.S. provisional patent application concerning composition of matter, ... achieve targeted tumor cell death.  This ... noncoding double stranded RNA molecules (VSRNAs) which interfere with ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
(Date:7/9/2014)... More scientific research into the metabolism of stromal support ... the metabolism of these cell types in the development ... diabetes, inflammatory conditions and cancer. That was the conclusion ... KU Leuven in the leading journal Nature . ... sort of wake-up call. The metabolism of cancer cells ...
(Date:7/9/2014)... injection drug users in Russia might contribute to ... study, conducted by researchers from Boston University Schools ... St. Petersburg Pavlov State University, sought to discover ... outcomes of a cohort of HIV-positive people with ... were arrested by police were more likely to ...
(Date:7/9/2014)... release is available in French . ... in 14 year old teens, including brain structure and function, ... accuracy who will go on to develop binge drinking within ... conscientiousness, and other variables such as life events and a ... binge drinking. Whether or not the child had had ...
(Date:7/9/2014)... and extinctions around the world have been linked ... new research from the National Institute for Mathematical ... ranavirus, may also contribute. , In a ... which causes severe hemorrhage of internal organs in ... wood frogs if they are exposed to the ...
(Date:7/9/2014)... National Institute of Allergy and Infectious Diseases (NIAID), ... launched an early-stage clinical trial of CRS3123, an ... difficile ( C. difficile ) infection. CRS3123 ... that inhibits C. difficile growth while sparing normal ... enroll up to 30 healthy men and women ...
Breaking Medicine News(10 mins):Health News:Wake-up call for more research into cell metabolism 2Health News:BU researchers relate arrests with HIV risk environment 2Health News:What drives a child to abuse alcohol? 2Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2
... among those who apply the chemicals, study shows , ... pesticides have double the normal risk of developing a ... (monoclonal gammopathy of undetermined significance) and characterized by an ... monitoring because it can lead to multiple myeloma, a ...
... of Facebook, Twitter coincides with 30% drop in hours spent ... American kids and their parents are now spending more hours ... eroding the amount of time families spend together. , That,s ... week that families interact as group has fallen by nearly ...
... Power Plate(R) North America (PPNA), the global ... trend in fitness and beauty to the greater Los ... studio opening this month for the summer in Brentwood, ... machines, "Power Plate(R) - The Experience" will provide group ...
... stay up at night worrying whether they are going to develop ... and middle age is a lifetime away. As ... Feinberg School of Medicine have found that young adults (18 to ... a treadmill test -- are two to three times more likely ...
... scientists are among a multinational collaborative group to have ... European Union. The research will focus on ... common to all solid tumours. Hypoxia causes a ... resistant to radiotherapy and most forms of chemotherapy; as ...
... June 18 George Dahlman, senior vice president of ... testified today before the U.S. Senate Subcommittee on Defense ... cancer research program at the Department of Defense (DoD). ... determined that several blood cancers, including chronic lymphocytic leukemia ...
Cached Medicine News:Health News:Pesticides Linked to Blood Disorder 2Health News:Surging Internet Use Cutting Into Family Time 2Health News:Surging Internet Use Cutting Into Family Time 3Health News:Power Plate(R) Opens Cutting-Edge Studio in L.A. 2Health News:Aerobically unfit young adults on road to diabetes in middle age 2Health News:$16.8 million study will breathe new life into cancer battle 2Health News:The Leukemia & Lymphoma Society Calls for Blood Cancer Research Program at the Department of Defense 2
The generously sized STERILE VIEW Monk Hood from DePuy provides splash protection in the chin and neck areas from body fluids and liquids. Shoulder cut outs and ties ensure a comfortable fit. This pr...
STERILE VIEW Barrier Sleeves combine superior protection against contaminants with unsurpassed comfort and the convenience of universal sizing....
... UltraFit PK System rede phines sharpness ... trephine program for penetrating keratoplasty. Advanced ... cutting edge to achieve the critical fit ... disposable and fully customized system enables surgeons ...
Digital Imaging for Optical Screening:,Diabetes, Glaucoma Macular Degeneration, and other retinal disease....
Medicine Products: